|
20240104 Temple Pathology JC - The use of diagnostic patterns for interventional cytopathology during rapid on-site evaluation and final classification |
01/04/2024 - 12:00pm to 1:00pm CST |
|
20240201 Temple Pathology JC -Prediction of Risk for Myeloid Malignancy in Clonal Hematopoiesis |
02/01/2024 - 12:00pm to 1:00pm CST |
|
20240314 Temple Pathology JC -Revision of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis Classification Schema for Melanocytic Lesions |
03/14/2024 - 12:00pm to 1:00pm CDT |
|
20240404 Temple Pathology JC -The Impact of the 2022 WHO Classification of Thyroid Neoplasms on Everyday Practice of Cytopathology and A reappraisal of the epidemiology of Spitz neoplasms in the molecular era: A retrospective cohort study |
04/04/2024 - 12:00pm to 1:00pm CDT |
|
20240502 Temple Pathology JC -Melanocytic naevi, melanocytomas and emerging concepts |
05/02/2024 - 12:00pm to 1:00pm CDT |
|
20240606 Temple Pathology JC - Cell Stem Cell: Outer Radial Glia-like Cancer Stem Cells Contribute to Heterogeneity of Glioblastoma |
06/06/2024 - 12:00pm to 1:00pm CDT |
|
20240711 Temple Pathology JC -A review and analysis of outcomes in randomized clinical trials of plasma transfusion in patients with bleeding or for the prevention of bleeding: The BEST collaborative study |
07/11/2024 - 12:00pm to 1:00pm CDT |
|
20240801 Temple Pathology JC - Tumor Typing of Endocervical Adenocarcinoma: Contemporary Review and Recommendations From the International Society of Gynecological Pathologists |
08/01/2024 - 12:00pm to 1:00pm CDT |
|
20240905 Temple Pathology JC -Prevalence and interpretation of AFF immunostain of DEK::AFF2 fusion‑associated papillary squamous cell carcinoma in a retrospective cohort of recurrent sinonasal papillomas |
09/05/2024 - 12:00pm to 1:00pm CDT |
|
20241003 Temple Pathology JC -Papillary Renal Cell Carcinoma: Evolving Classification by Combined Morphologic and Molecular Means |
10/03/2024 - 12:00pm to 1:00pm CDT |